American Oriental Bioengineering (AOB) Submits Plan to Cure Stock Price Deficiency
Tweet
Share
E-mailGet Alerts AOB Hot Sheet
Join SI Premium – FREE
American Oriental Bioengineering, Inc. (NYSE: AOB) today announced that the Company submitted its plan to cure stock price deficiency with respect to the listing standard of the New York Stock Exchange on October 5, 2011.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
- Kimbell Royalty closes $221.2M mineral rights acquisition
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
